Specific HIF-2α (Hypoxia-Inducible Factor-2) Inhibitor PT2385 Mitigates Placental Dysfunction In Vitro and in a Rat Model of Preeclampsia (RUPP).
Arthur ColsonChristophe Louis DepoixIsaline LambertCamille LeducqMarie BedinMichèle De BeukelaerLaurent GattoAxelle LoriotMaureen Peers de NieuwburghKhadija BouhnaPamela BaldinCorinne HubinontPierre SonveauxFrédéric DebièvePublished in: Hypertension (Dallas, Tex. : 1979) (2023)
These results highlight HIF-2α as a new player in our understanding of placental dysfunction and support the use of PT2385 to treat severe preeclampsia in humans.